Skip to content
healthcare.dev

Terazosin hydrochloride

NDC 68788-9816, Terazosin hydrochloride, capsule, from Preferred Pharmaceuticals, Inc.

Product NDC
68788-9816
Status
Listed
Labeler
Preferred Pharmaceuticals, Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-9816 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
68788-9816-168788981601100 CAPSULE in 1 BOTTLE (68788-9816-1)
68788-9816-36878898160330 CAPSULE in 1 BOTTLE (68788-9816-3)
68788-9816-66878898160660 CAPSULE in 1 BOTTLE (68788-9816-6)
68788-9816-96878898160990 CAPSULE in 1 BOTTLE (68788-9816-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d8fd052-b478-447e-a884-74fcd21275bb

Use it

Look up 68788-9816 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-9816 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-9816. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.